NFKB1 and atherosclerosis: Additionally, Ueland et al. highlighted DKK1 as a new mediator for platelet-mediated endothelial cell activation, underscoring its critical role in the pathological process of atherosclerosis through the inhibition of the Wnt/beta-catenin signaling pathway and the activation of the NF-kB pathway [18].